908 Devices Inc.
For the period ended Mar 31, 2025. Filed May 13, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 13, 2025
MASS$9.99-13.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Stockholders’ Equity
(in thousands, except share amounts)
| | | | | | | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| · · · · · · · · · · Accumulated · · · · · · | |||||||||||||||||
| · · · · Additional · · Other · · · · Total | |||||||||||||||||
| · · Common Stock · · Paid-in · · Comprehensive · · Accumulated · · Stockholders' | |||||||||||||||||
| · Shares · Amount · Capital · · Income · Deficit · Equity | |||||||||||||||||
| Balances at December 31, 2024 | | 35,098,493 | | $35 | | $356,216 | | $1,146 | | $(242,805) | | $114,592 | |||||
| Issuance of common stock upon exercise of stock options | | 8,266 | | | — | | | 11 | | | — | | | — | | | 11 |
| Stock-based compensation expense | | — | | | — | | | 2,365 | | | — | | | — | | | 2,365 |
| Vesting of restricted stock units | | 632,797 | | | 1 | | | — | | | — | | | — | | | 1 |
| Net income | | — | | | — | | | — | | | — | | | 43,603 | | | 43,603 |
| Foreign currency translation adjustments | | — | | | — | | | — | | | (7) | | | — | | | (7) |
| Foreign currency translation adjustments reclassed out of accumulated other comprehensive income related to discontinued operations | | — | | | — | | | — | | | (1,125) | | | — | | | (1,125) |
| Unrealized loss on marketable securities | | — | | | — | | | — | | | (16) | | | — | | | (16) |
| Balances at March 31, 2025 | | 35,739,556 | | $36 | | $358,592 | | $(2) | | $(199,202) | | $159,424 | |||||
| | | | | | | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| · · · · · · · · · · Accumulated · · · · · · | |||||||||||||||||
| · · · · Additional · · Other · · · · Total | |||||||||||||||||
| · · Common Stock · · Paid-in · · Comprehensive · · Accumulated · · Stockholders' | |||||||||||||||||
| · Shares · Amount · Capital · · Income · Deficit · Equity | |||||||||||||||||
| Balances at December 31, 2023 | | 32,519,023 | | $33 | | $334,692 | | $1,365 | | $(170,599) | | $165,491 | |||||
| Issuance of common stock upon exercise of stock options | 34,563 | | | — | | | 61 | | | — | | | — | | | 61 | |
| Stock-based compensation expense | — | | | — | | | 2,643 | | | — | | | — | | | 2,643 | |
| Vesting of restricted stock units | | 370,511 | | | — | | | — | | | — | | | — | | | — |
| Net loss | — | | | — | | | — | | | — | | | (10,917) | | | (10,917) | |
| Foreign currency translation adjustments | | — | | | — | | | — | | | (370) | | | — | | | (370) |
| Unrealized loss on marketable securities | | — | | | — | | | — | | | (15) | | | — | | | (15) |
| Balances at March 31, 2024 | | 32,924,097 | | $33 | | $337,396 | | $980 | | $(181,516) | | $156,893 | |||||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.